SWOG S1609

Primary Category:

Treatment Protocols

Disease Category:

Molecular Profiling



DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors


Eligible for screening study DCP 001

Please see http://www.swogstat.org/accrual/dart.htm for up-to-date accrual information and current cohort accrual status (i.e. open, closed, suspended).  The website is updated with the most current information daily.

S1609 is permanently closed to accrual, effective March 15, 2023.